142 related articles for article (PubMed ID: 31820386)
1. Analytical Platforms 3: Processing Samples via the RPPA Pipeline to Generate Large-Scale Data for Clinical Studies.
Siwak DR; Li J; Akbani R; Liang H; Lu Y
Adv Exp Med Biol; 2019; 1188():113-147. PubMed ID: 31820386
[TBL] [Abstract][Full Text] [Related]
2. RPPA SPACE: an R package for normalization and quantitation of Reverse-Phase Protein Array data.
Shehwana H; Kumar SV; Melott JM; Rohrdanz MA; Wakefield C; Ju Z; Siwak DR; Lu Y; Broom BM; Weinstein JN; Mills GB; Akbani R
Bioinformatics; 2022 Nov; 38(22):5131-5133. PubMed ID: 36205581
[TBL] [Abstract][Full Text] [Related]
3. Reverse-Phase Protein Array: Technology, Application, Data Processing, and Integration.
Coarfa C; Grimm SL; Rajapakshe K; Perera D; Lu HY; Wang X; Christensen KR; Mo Q; Edwards DP; Huang S
J Biomol Tech; 2021 Apr; 32(1):15-29. PubMed ID: 34025221
[TBL] [Abstract][Full Text] [Related]
4. Development of a robust classifier for quality control of reverse-phase protein arrays.
Ju Z; Liu W; Roebuck PL; Siwak DR; Zhang N; Lu Y; Davies MA; Akbani R; Weinstein JN; Mills GB; Coombes KR
Bioinformatics; 2015 Mar; 31(6):912-8. PubMed ID: 25380958
[TBL] [Abstract][Full Text] [Related]
5. Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.
Akbani R; Becker KF; Carragher N; Goldstein T; de Koning L; Korf U; Liotta L; Mills GB; Nishizuka SS; Pawlak M; Petricoin EF; Pollard HB; Serrels B; Zhu J
Mol Cell Proteomics; 2014 Jul; 13(7):1625-43. PubMed ID: 24777629
[TBL] [Abstract][Full Text] [Related]
6. Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas.
Li J; Akbani R; Zhao W; Lu Y; Weinstein JN; Mills GB; Liang H
Cancer Res; 2017 Nov; 77(21):e51-e54. PubMed ID: 29092939
[TBL] [Abstract][Full Text] [Related]
7. Reverse phase protein arrays in signaling pathways: a data integration perspective.
Creighton CJ; Huang S
Drug Des Devel Ther; 2015; 9():3519-27. PubMed ID: 26185419
[TBL] [Abstract][Full Text] [Related]
8. Platforms and Pipelines for Proteomics Data Analysis and Management.
Codrea MC; Nahnsen S
Adv Exp Med Biol; 2016; 919():203-215. PubMed ID: 27975218
[TBL] [Abstract][Full Text] [Related]
9. Generation of Raw RPPA Data and Their Conversion to Analysis-Ready Data.
Akbani R; Ling S; Lu Y
Adv Exp Med Biol; 2019; 1188():165-180. PubMed ID: 31820388
[TBL] [Abstract][Full Text] [Related]
10. Reverse-Phase Protein Array: Technology, Application, Data Processing, and Integration.
Coarfa C; Grimm SL; Rajapakshe K; Perera D; Lu HY; Wang X; Christensen KR; Mo Q; Edwards DP; Huang S
J Biomol Tech; 2021 Jan; ():. PubMed ID: 33584151
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility and Crossplatform Validation of Reverse-Phase Protein Array Data.
Byron A
Adv Exp Med Biol; 2019; 1188():181-201. PubMed ID: 31820389
[TBL] [Abstract][Full Text] [Related]
12. Spatial normalization of reverse phase protein array data.
Kaushik P; Molinelli EJ; Miller ML; Wang W; Korkut A; Liu W; Ju Z; Lu Y; Mills G; Sander C
PLoS One; 2014; 9(12):e97213. PubMed ID: 25501559
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of reverse phase protein array for molecular classification of breast cancer.
Negm OH; Muftah AA; Aleskandarany MA; Hamed MR; Ahmad DA; Nolan CC; Diez-Rodriguez M; Tighe PJ; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2016 Jan; 155(1):25-35. PubMed ID: 26661092
[TBL] [Abstract][Full Text] [Related]
14. Topological integration of RPPA proteomic data with multi-omics data for survival prediction in breast cancer via pathway activity inference.
Kim TR; Jeong HH; Sohn KA
BMC Med Genomics; 2019 Jul; 12(Suppl 5):94. PubMed ID: 31296204
[TBL] [Abstract][Full Text] [Related]
15. Using feature selection and Bayesian network identify cancer subtypes based on proteomic data.
Wang Y; Gao X; Ru X; Sun P; Wang J
J Proteomics; 2023 May; 280():104895. PubMed ID: 37024076
[TBL] [Abstract][Full Text] [Related]
16. Clustering and Network Analysis of Reverse Phase Protein Array Data.
Byron A
Methods Mol Biol; 2017; 1606():171-191. PubMed ID: 28502001
[TBL] [Abstract][Full Text] [Related]
17. Reverse Phase Protein Arrays.
Davis JB; Andes S; Espina V
Methods Mol Biol; 2021; 2237():103-122. PubMed ID: 33237412
[TBL] [Abstract][Full Text] [Related]
18. High-Density Serum/Plasma Reverse Phase Protein Arrays.
Hellström C; Dodig-Crnković T; Hong MG; Schwenk JM; Nilsson P; Sjöberg R
Methods Mol Biol; 2017; 1619():229-238. PubMed ID: 28674890
[TBL] [Abstract][Full Text] [Related]
19. TCPA v3.0: An Integrative Platform to Explore the Pan-Cancer Analysis of Functional Proteomic Data.
Chen MM; Li J; Wang Y; Akbani R; Lu Y; Mills GB; Liang H
Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S15-S25. PubMed ID: 31201206
[TBL] [Abstract][Full Text] [Related]
20. The effects of sample handling on proteomics assessed by reverse phase protein arrays (RPPA): Functional proteomic profiling in leukemia.
Horton TM; Hoff FW; van Dijk A; Jenkins GN; Morrison D; Bhatla T; Hogan L; Romanos-Sirakis E; Meyer J; Carroll WL; Qiu Y; Wang T; Mo Q; Kornblau SM
J Proteomics; 2021 Feb; 233():104046. PubMed ID: 33212251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
